Achilles Therapeutics Prepares for Nasdaq Delisting and Liquidation Achilles Therapeutics has set March 20, 2025, as its final trading day on Nasdaq before delisting. The company plans to file for deregistration shortly after, ending its obligation to submit periodic reports. Following the delisting, trading will be limited to private negotiations or potential over-the-counter markets.3